Novel crs fragment peptide with immunopotentiating activity, and use thereof
AssigneeZymedi Co., Ltd.
InventorsSeongmin CHO, Sunghoon KIM
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel CRS fragment peptide with immune-enhancing activity and its uses, more specifically to a novel peptide consisting of the amino acid sequence of SEQ ID NO: 2 or an amino acid sequence having 95% or more sequence homology thereto, and its use as a vaccine adjuvant, an anticancer agent, and an antiviral composition. The peptide disclosed in the present invention is a CRS fragment disclosed for the first time in this specification, exhibiting anticancer activity, immune function enhancement, and antiviral activity.
Claims21
-15. (canceled)
A method for preventing or treating a viral infection, comprising administering to a subject in need thereof an effective amount of a composition comprising a peptide comprising consecutive amino acids sequence which is from any amino acid selected from 99th to 140th amino acids to any amino acid selected from 185th to 228th amino acids in the amino acid sequence of SEQ ID NO:1;
- or a peptide comprising an amino acid sequence having 80% or more homology with the peptide as an active ingredient.
A peptide consisting of the amino acid sequence of SEQ ID NO:
- 2 or an amino acid sequence having 95% or more sequence homology thereto.
Dependencies are inferred from the claim text.